Clinical Research Directory
Browse clinical research sites, groups, and studies.
Reducing Stigma in People Who Inject Drugs (PWID) With HIV Using a Rapid Start Antiretroviral Therapy Intervention (ART)
Sponsor: Yale University
Summary
This study seeks to develop an RS-ART implementation strategy by utilizing the Delphi method and interviewing experts and PWID regarding their experiences with ART. This strategy will then be pilot tested in a randomized controlled trial (Aim 3). The research will not impact the type of medication and dose prescribed, but rather, how soon providers are able to prescribe ART after diagnosis. The focus of this registration is Aim 3.
Official title: Reducing Stigma in People Who Inject Drugs With HIV Using a Rapid Start Antiretroviral Therapy Intervention (RS-ART)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
135
Start Date
2025-11-04
Completion Date
2028-05
Last Updated
2026-01-29
Healthy Volunteers
No
Interventions
Rapid-Start ART (RS-ART)
ART initiation within 7 days of HIV diagnosis. (RS-ART intervention to be informed and developed in Aims 1 and 2.) RS-ART is a strategy that focuses on clinical decision-making generally based solely on clinical criteria, and later organizing support for mental health, adherence, and management of comorbid conditions only after the patient has initiated ART.
Locations (3)
Kajang Prison
Kajang, Malaysia
Centre of Excellence for Research in AIDS (CERiA) - University of Malaya
Kuala Lumpur, Malaysia
Primary Healthcare Centers
Kuala Lumpur, Malaysia